NCT00226538View on ClinicalTrials.gov

Prediction of Drug Interactions With CYP2C9 Substrates

NACompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

August 31, 1999

Conditions

Healthy Volunteers

Interventions

DRUG

Phenytoin

DRUG

Rifampicin

DRUG

Diclophenac

DRUG

Fluconazole

Trial Locations (1)

Unknown

Hadassah Medical Organization, Jerusalem

All Listed Sponsors

lead

Hadassah Medical Organization

OTHER

NCT00226538 - Prediction of Drug Interactions With CYP2C9 Substrates | Biotech Hunter | Biotech Hunter